Earlier reports suggested Geltor was seeking as much as $100m, but the Archer Daniels Midland and Wilbur-Ellis-backed company has now seemingly secured $90m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

CSPC returned for the anti-tumour therapy developer's series B round having backed its $147m series A early last year.

Exor Seeds co-led a $26.7m round for Cowboy that will drive the electric bicycle maker's European expansion efforts.

Delta Dental Washington Seed Fund was among the participants in a $10.8m round for the pelvic bone implant developer.

The CNS disease therapy developer raised a further $20m, adding to a $45m close in April that included GV and Takeda Ventures.

UPMC Enterprises has contributed to a $20m series B extension for Cerevance, which is commercialising Rockefeller University research.

Septwolves Ventures participated in a $21.5m round for the X-ray equipment producer that was led by a China Construction Bank fund.

Boehringer Ingelheim Venture Fund followed an investment last September by contributing to a $26.8m round for the bacteria-based cancer drug developer.

Santen Ventures co-led a series B round to bring TAU faculty-founded Belkin Laser's funding total to $16.3m.